
The Omnipod 5 is now the first automated insulin delivery system available for both T1D and T2D in the US.

The Omnipod 5 is now the first automated insulin delivery system available for both T1D and T2D in the US.

Your daily dose of the clinical news you may have missed.

Results of a global analysis of over 30 million cases showed significantly higher odds for suicidal ideation among adults who received semaglutide vs other medications.

The increase in the adult population with and at risk for dementia portends future burden among groups and communities with the fewest resources to cope.

Your daily dose of the clinical news you may have missed.

Obstructive sleep apnea during pregnancy increases risk for gestational hypertension and preeclampsia; CPAP therapy may lower risk significantly.

Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.

Your daily dose of the clinical news you may have missed.

In secondary CVD prevention, low/moderate-dose statins plus ezetimibe were superior to high-dose statin for reducing biomarkers, myalgias but did not reduce MACE.

Patients with obesity face both physical and emotional challenges during the COVID-19 pandemic. How can PCPs help?

The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.

The sGC activator represents a novel approach to modulating the nitric oxide-soluble sGC-cyclic guanosine monophosphate pathway.

Do you know the ACIP-preferred influenza vaccine for adults aged ≥65 yrs? The cut-off age for HPV vaccination? The time between the 2-dose mpox series? More, here.

Simple criteria for lung cancer screening identified more people who would highly benefit, including more from racial/ethnic minority groups.

Your daily dose of the clinical news you may have missed.

Regular aspirin use was associated with a greater absolute reduction in CRC incidence among adults with unhealthier lifestyles, according to recent research.

Your daily dose of the clinical news you may have missed.

Results of the 3-year SURMOUNT-1 study reflect the longest trial to date of tirzepatide in adults with overweight/obesity and risk for developing T2D.

Younger US veterans with PTSD and type 2 diabetes who no longer met criteria for PTSD were less likely to initiate insulin and had reduced odds of mortality.

Investigators found as much as a 2-fold difference in being diagnosed with dementia across the US, even after controlling for common individual risk factors.